A director at Dedicare AB sold 49,141 shares at 49.113SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Sales and adj. EBIT +2% vs ABGSCe ‘23e EBIT up 6% as we add UK acquisition to numbers Less cyclical than the average staffing company
Acquires Templars Medical Agency Ltd. Sees it as a platform to build from in UK and Ireland Dedicare’s vision is to become a leading player in Europe
43% sales growth y-o-y, 37% organic We raise ’23e sales & EBIT estimates by 6% and 10% New fair value range of SEK 89-116 (82-113)
Q2 report due on 15 July Dedicare is taking market share in a growing market New value range of SEK 82-113
~12% sales growth last 5Y 28% sales growth and above-target EBIT margin in ’22e Fair value range of SEK 72-114, 5x-8x ’22e EV/EBIT
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.